Ascend Capital’s MetLife MET Stock Holding History

Ascend Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-336,044	Closed	-$14.7M	–	204
2018 Q2	$14.7M	Sell	336,044 -352,337	-51%	-$16.4M	0.69%	48
2018 Q1	$31.6M	Buy	+688,381	New	+$33.4M	1.29%	22
2017 Q4	–	Sell	-89,943	Closed	-$4.67M	–	235
2017 Q3	$4.67M	Sell	89,943 -1,105,741	-92%	-$53.9M	0.18%	109
2017 Q2	$58.5M	Buy	1,195,684 +116,991	+11%	+$5.43M	2.72%	3
2017 Q1	$50.8M	Buy	1,078,693 +838,043	+348%	+$40M	2.3%	3
2016 Q4	$11.6M	Buy	+240,650	New	+$11M	0.58%	61
2014 Q3	–	Sell	-235,021	Closed	-$11.6M	–	199
2014 Q2	$11.6M	Sell	235,021 -28,772	-11%	-$1.35M	0.39%	86
2014 Q1	$12.4M	Buy	263,793 +155,632	+144%	+$7.15M	0.32%	94
2013 Q4	$5.2M	Sell	108,161 -643,403	-86%	-$28.8M	0.16%	133
2013 Q3	$31.4M	Buy	751,564 +160,373	+27%	+$6.91M	1.17%	21
2013 Q2	$24.1M	Buy	+591,191	New	+$21.7M	1.03%	28

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ascend Capital's MET Position: Q3 2018 in Review

Ascend Capital sold out of MetLife (MET) in Q3 2018, closing a stake of 336,044 shares — an estimated $14.7M sold.

Ascend Capital first reported a position in MET in Q2 2013 and held it in 11 quarters. The position peaked at $58.5M in Q2 2017. 1,012 funds tracked by Wall St. Rank hold MET as of Q3 2018.

Ascend Capital reported no remaining MetLife position as of Q3 2018 after selling out during the quarter.
Ascend Capital sold 336,044 MetLife shares in Q3 2018, an estimated $14.7M.
Ascend Capital first reported a position in MetLife in Q2 2013 and held it in 11 quarters.
Ascend Capital's MetLife position peaked at $58.5M in Q2 2017.
1,012 funds tracked by Wall St. Rank held MetLife as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.